Fennec Pharmaceuticals Inc. (FENC) insider trading.
In Q3 2026, insiders at Fennec Pharmaceuticals Inc. reported 27 non-derivative transactions on 21 Forms 3, 4 and 5: 0 open-market purchases and 6 sales worth $1.5M.
- Transactions
- 27
- Purchases (P)
- 0
- Sales (S)
- 6
- Net shares, P minus S
- -132,144
- Insiders
- 7
- Last filed
- 2026-09-16
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Raykov Rosty | Other | 7 | 0 | 3 |
| Andrade Robert | Officer · CHIEF FINANCIAL OFFICER | 5 | 0 | 1 |
| Sayad Pierre Sargis | Officer · Chief Medical Officer | 4 | 0 | 1 |
| Hackman Jeffrey S. | Director, Officer · Chief Executive Officer | 3 | 0 | 0 |
| Evans Terry L | Officer · Chief Commercial Officer | 3 | 0 | 0 |
| Cioffi Christiana Marie | Officer · Chief Strategy Officer | 3 | 0 | 0 |
| Brughera Marco Maria | Director | 2 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Brughera Marco Maria | M (A) | 15,545 | $2.11 | 15,545 | Form 4 |
| 2026-09-15 | Brughera Marco Maria | S (D) | 15,545 | $10.29 | 0 | Form 4 |
| 2026-09-01 | Raykov Rosty | S (D) | 10,000 | $12.11 | 124,411 | Form 4 |
| 2026-08-31 | Raykov Rosty | A (A) | 2,778 | $0 | 134,411 | Form 4 |
| 2026-08-31 | Andrade Robert | A (A) | 1,703 | $0 | 241,306 | Form 4 |
| 2026-08-31 | Hackman Jeffrey S. | A (A) | 1,159 | $0 | 66,302 | Form 4 |
| 2026-08-31 | Evans Terry L | A (A) | 168 | $0 | 21,519 | Form 4 |
| 2026-08-31 | Sayad Pierre Sargis | A (A) | 168 | $0 | 21,519 | Form 4 |
| 2026-08-31 | Sayad Pierre Sargis | S (D) | 12,000 | $12.18 | 9,519 | Form 4 |
| 2026-08-31 | Cioffi Christiana Marie | A (A) | 156 | $0 | 24,644 | Form 4 |
| 2026-08-28 | Andrade Robert | M (A) | 21,928 | $5.1 | 239,603 | Form 4 |
| 2026-08-27 | Andrade Robert | S (D) | 75,000 | $11.78 | 217,675 | Form 4 |
| 2026-08-03 | Raykov Rosty | S (D) | 10,000 | $9.58 | 131,633 | Form 4 |
| 2026-07-31 | Andrade Robert | A (A) | 1,703 | $0 | 292,675 | Form 4 |
| 2026-07-31 | Raykov Rosty | A (A) | 2,778 | $0 | 141,633 | Form 4 |
| 2026-07-31 | Hackman Jeffrey S. | A (A) | 1,159 | $0 | 65,143 | Form 4 |
| 2026-07-31 | Evans Terry L | A (A) | 168 | $0 | 21,351 | Form 4 |
| 2026-07-31 | Sayad Pierre Sargis | A (A) | 168 | $0 | 21,351 | Form 4 |
| 2026-07-31 | Cioffi Christiana Marie | A (A) | 156 | $0 | 24,488 | Form 4 |
| 2026-07-01 | Raykov Rosty | A (A) | 2,778 | $0 | 132,857 | Form 4 |
| 2026-07-01 | Raykov Rosty | M (A) | 15,597 | $2.45 | 148,454 | Form 4 |
| 2026-07-01 | Raykov Rosty | S (D) | 9,599 | $10.41 | 138,855 | Form 4 |
| 2026-06-30 | Andrade Robert | A (A) | 1,703 | $0 | 290,972 | Form 4 |
| 2026-06-30 | Hackman Jeffrey S. | A (A) | 1,159 | $0 | 63,984 | Form 4 |
| 2026-06-30 | Evans Terry L | A (A) | 168 | $0 | 21,183 | Form 4 |
| 2026-06-30 | Sayad Pierre Sargis | A (A) | 168 | $0 | 21,183 | Form 4 |
| 2026-06-30 | Cioffi Christiana Marie | A (A) | 156 | $0 | 24,332 | Form 4 |
Transaction codes in this quarter
Get FENC insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1211583&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · FENC company page · Fennec Pharmaceuticals Inc. on SEC.gov
Questions
Are insiders buying or selling Fennec Pharmaceuticals Inc. (FENC)?
In Q3 2026, insiders at Fennec Pharmaceuticals Inc. reported 27 non-derivative transactions on 21 Forms 3, 4 and 5: 0 open-market purchases and 6 sales worth $1.5M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Fennec Pharmaceuticals Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/fenc.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.